Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andoni Garitano-Trojaola

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 26, 2024
Accelerating CAR-T Cell Therapies with Small-Molecule InhibitorsKatrin Mestermann, Andoni Garitano-Trojaola, Michael Hudecek
International Journal of Molecular Sciences|July 27, 2013
Long non-coding RNAs in haematological malignanciesAndoni Garitano-Trojaola, Xabier Agirre, Felipe Prósper, et al.
International Review of Cell and Molecular Biology|September 5, 2022
mRNA-based therapies: Preclinical and clinical applicationsMusga Qureischi, Julia Mohr, Estibaliz Arellano-Viera, et al.
Oncotarget|March 22, 2018
Deregulation of <i>linc-PINT</i> in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cellsAndoni Garitano-Trojaola, Edurne San José-Enériz, Teresa Ezponda, et al.
The Oncologist|February 12, 2020
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF-MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System InvolvementMatteo Claudio Da Vià, Antonio Giovanni Solimando, Andoni Garitano-Trojaola, et al.
Communications Biology|June 26, 2021
Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemiaAndoni Garitano-Trojaola, Ana Sancho, Ralph Götz, et al.
Leukemia|July 21, 2018
Spectrum and functional validation of PSMB5 mutations in multiple myelomaSantiago Barrio, Thorsten Stühmer, Matteo Da-Viá, et al.
Blood|June 11, 2021
Cereblon enhancer methylation and IMiD resistance in multiple myelomaLarissa Haertle, Santiago Barrio, Umair Munawar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2022
Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple MyelomaLarissa Haertle, Santiago Barrio, Umair Munawar, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 26, 2024
Accelerating CAR-T Cell Therapies with Small-Molecule InhibitorsKatrin Mestermann, Andoni Garitano-Trojaola, Michael Hudecek
International Journal of Molecular Sciences|July 27, 2013
Long non-coding RNAs in haematological malignanciesAndoni Garitano-Trojaola, Xabier Agirre, Felipe Prósper, et al.
International Review of Cell and Molecular Biology|September 5, 2022
mRNA-based therapies: Preclinical and clinical applicationsMusga Qureischi, Julia Mohr, Estibaliz Arellano-Viera, et al.
Oncotarget|March 22, 2018
Deregulation of <i>linc-PINT</i> in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cellsAndoni Garitano-Trojaola, Edurne San José-Enériz, Teresa Ezponda, et al.
The Oncologist|February 12, 2020
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF-MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System InvolvementMatteo Claudio Da Vià, Antonio Giovanni Solimando, Andoni Garitano-Trojaola, et al.
Communications Biology|June 26, 2021
Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemiaAndoni Garitano-Trojaola, Ana Sancho, Ralph Götz, et al.
Leukemia|July 21, 2018
Spectrum and functional validation of PSMB5 mutations in multiple myelomaSantiago Barrio, Thorsten Stühmer, Matteo Da-Viá, et al.
Blood|June 11, 2021
Cereblon enhancer methylation and IMiD resistance in multiple myelomaLarissa Haertle, Santiago Barrio, Umair Munawar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2022
Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple MyelomaLarissa Haertle, Santiago Barrio, Umair Munawar, et al.
Pageof 1